MTOR and angiomyolipoma: Consider the use of mTOR inhibitors in the immunosuppressive regimen, also to prevent angiomyolipomas bleeding in native kidneys and, if necessary, to control other manifestations of the disease.Consider nephrectomy of native kidneys depending on kidney size and angiomyolipomas due to risk of bleeding.